If you or a loved one is in immediate crisis: call 988 (Suicide & Crisis Lifeline) or 1-800-662-HELP (SAMHSA National Helpline). This page is informational and not a replacement for medical advice. Decisions about medication for opioid use disorder require consultation with a qualified prescriber.
Decision Guide · Updated May 2026
Medical Detox
vs
MAT (Medication-Assisted Treatment)
Detox vs MAT (Medication-Assisted Treatment)
Compare Medical Detox and MAT (Medication-Assisted Treatment) across 12 decision points — cost, evidence, named criteria for choosing each option.
Last reviewed May 12, 2026
SAMHSA & NIDA sourced
12 data points
10 FAQ
6 sources
Talk to a licensed clinical advisor
- Free & confidential
- 24/7 availability
- Insurance verified in 5 min
- HIPAA-compliant
- No pressure, just answers
Quick Verdict
·
~30 sec read
Reviewed by RehabHive Editorial Team · Last updated May 12, 2026
Detox and MAT serve different purposes and are typically combined, not chosen between. Medical detox manages acute physical withdrawal symptoms over 3-7 days; MAT prevents relapse and supports long-term recovery over months to years using FDA-approved medications. Best practice: medical detox initiates MAT during withdrawal (e.g., buprenorphine induction during opioid detox) so the patient transitions seamlessly from withdrawal management into ongoing MAT-supported recovery. Detox alone — without MAT or other recovery treatment — has very high relapse rates (>80% within 30 days for opioid users).
Also comparing
Other treatment comparisons
I
Inpatient vs Outpatient Rehab
Inpatient vs outpatient rehab 2026: ASAM levels, cost ($15k-30k vs $5k-10k), duration, success rates, when to choose each. Evidence-based decision guide.
C
CBT vs DBT Therapy
M
Methadone vs Suboxone for Opioid Use Disorder
Methadone vs Suboxone (buprenorphine) for opioid use disorder 2026: efficacy, overdose risk, access, cost compared. Evidence-based MOUD guide with sources.
3
30-Day vs 90-Day Rehab
30-day vs 90-day rehab 2026: NIDA outcome research, $15k-25k vs $30k-60k cost, insurance approval, who needs longer. Evidence-based duration decision.
Save / Send
Email
Side-by-side comparison (12 decision points)
| Factor | Medical Detox | MAT (Medication-Assisted Treatment) |
|---|---|---|
| Purpose | Manage acute withdrawal safely | Long-term relapse prevention |
| Duration | 3-7 days typically | Months to years; sometimes indefinite |
| Setting | Hospital, residential Level 3.7/4.0, or outpatient | Outpatient (office, OTP, or specialty pharmacy) |
| ASAM Level | 3.7 or 4.0 (medically monitored) | 1.0 outpatient typical; may continue through 2.1, 3.5 |
| Substances Treated | Alcohol, opioids, benzodiazepines, all detoxable substances | OUD (buprenorphine/methadone/naltrexone); AUD (naltrexone/acamprosate/disulfiram) |
| Medications Used | Benzodiazepines (alcohol), buprenorphine taper or initiation (opioids), supportive meds | Buprenorphine, methadone, naltrexone, acamprosate, disulfiram |
| Cost (typical) | $5,000-$15,000 for 5-7 day inpatient | $10-$30/week generic outpatient; $0-$200/month Vivitrol with assistance |
| Insurance Coverage | Covered with prior auth; ASAM Level 3.7 benefit | Covered under SUD pharmacy + behavioral health benefits |
| Recovery Outcome | Stabilization only; high relapse if not followed by treatment | 50% lower OUD overdose mortality vs no-medication treatment (NIDA) |
| SAMHSA Recommendation | Necessary for some withdrawal; not standalone treatment | First-line for OUD per TIP 63 |
| Compatible with | Required step before some MAT (Vivitrol) | CBT, DBT, 12-step, group, family therapy |
| Best Practice | Initiate MAT during detox for OUD/AUD | Combine with therapy for behavioral and psychological dimensions |
Pros and cons
Medical Detox
Pros
- <strong>Manages dangerous withdrawal safely.</strong> Medical detox prevents seizures (alcohol/benzodiazepine withdrawal can be fatal), severe dehydration, suicidal ideation peaks, and unmanageable cravings during the most physically uncomfortable phase.
- <strong>Required before some MAT.</strong> Naltrexone (Vivitrol) requires 7-10 days opioid-free before initiation; detox provides that medically supervised window.
- <strong>24-hour medical monitoring.</strong> Hospital or residential Level 3.7/4.0 detox offers 24-hour nursing assessment, IV fluids, anticonvulsants, blood pressure management, and safety supervision.
- <strong>Initiates MAT during stabilization.</strong> Best-practice detox protocols start MAT (buprenorphine for OUD, naltrexone for AUD) during the detox stay so the patient transitions seamlessly into long-term recovery.
- <strong>Insurance covers as separate level.</strong> ASAM Level 3.7 (medically monitored withdrawal) is covered separately from residential rehab on most insurance plans, typically 3-7 days with prior auth.
- <strong>Single-event commitment.</strong> Detox is a defined 3-7 day intervention. Patients hesitant about long-term commitment may engage with detox as an entry point.
Cons
- <strong>Detox alone has >80% relapse rate (OUD).</strong> NIDA: opioid detox without MAT continuation has >80% relapse within 30 days. Detox alone is not recommended for OUD per SAMHSA TIP 63.
- <strong>Detox alone increases overdose risk.</strong> Loss of tolerance during detox dramatically increases overdose risk if patient relapses (lower-tolerance dose now lethal). Mortality spikes in the 30 days post-detox.
- <strong>Single intervention, no long-term protection.</strong> Detox addresses physical withdrawal but does not prevent the relapse drivers (cravings, environmental triggers, psychological dependence).
- <strong>May not be necessary for all substances.</strong> Stimulant (cocaine, methamphetamine) withdrawal is typically manageable in outpatient settings without medical detox. Marijuana withdrawal is mild. Alcohol and benzo withdrawal require detox; opioid withdrawal is uncomfortable but rarely life-threatening.
MAT (Medication-Assisted Treatment)
Pros
- <strong>Long-term relapse prevention.</strong> MAT provides ongoing pharmacological protection against relapse. Buprenorphine and methadone reduce opioid relapse 50% vs no-medication treatment. Naltrexone reduces AUD relapse 30%.
- <strong>Evidence-based standard of care.</strong> SAMHSA TIP 63, ASAM National Practice Guideline, and WHO Essential Medicines List all recommend MAT as first-line for OUD. Detox alone is not recommended for OUD.
- <strong>Reduces overdose mortality 50%.</strong> NIDA: patients on MAT (buprenorphine or methadone) for OUD have 50% lower overdose mortality vs no-medication treatment over 12 months.
- <strong>Continues during outpatient transition.</strong> MAT continues seamlessly from detox through outpatient — buprenorphine prescribed by any DEA-registered prescriber; methadone at SAMHSA-certified OTPs; Vivitrol monthly injections.
- <strong>Reduces cravings and withdrawal long-term.</strong> Buprenorphine and methadone occupy opioid receptors, eliminating cravings and providing physical stability. Naltrexone blocks opioid effect, eliminating reinforcement.
- <strong>Compatible with all therapy modalities.</strong> MAT works alongside CBT, DBT, group therapy, 12-step, and family therapy. Medication is foundational; therapy addresses behavioral and psychological dimensions.
Cons
- <strong>Long-term commitment.</strong> MAT is typically continued months to years (sometimes indefinitely). Some patients prefer abstinence-focused approaches.
- <strong>Methadone requires daily OTP visits initially.</strong> First 90 days of methadone require daily clinic dispensing at SAMHSA-certified OTPs (take-home doses earned gradually). Buprenorphine via prescription has no daily-visit requirement.
- <strong>Stigma in 12-step communities.</strong> Some traditional 12-step communities historically considered MAT "not truly sober." This stigma is declining but persists in some recovery communities.
- <strong>Insurance prior auth requirements.</strong> Brand Suboxone, Sublocade, and Vivitrol typically require prior auth and may have step-therapy on generic buprenorphine first.
When to choose each option
Named decision criteria for matching your specific situation to the right option.
When to choose Medical Detox
Primary indicators
- Active physical withdrawal symptoms
- Alcohol or benzodiazepine dependence (seizure risk)
- Severe opioid withdrawal requiring 24-hour monitoring
Additional considerations
- Need to be opioid-free before Vivitrol or naltrexone
- Unsafe to detox at home (no support, severe co-occurring medical)
- Initial stabilization before residential or outpatient treatment
When to choose MAT (Medication-Assisted Treatment)
Best-fit scenarios
- OUD diagnosis (SAMHSA recommends MAT first-line)
- AUD with prior relapse on abstinence-only approaches
- High relapse risk per ASAM dimensions
Further considerations
- Long-term recovery goal (months to years)
- Co-occurring chronic pain on opioids
- Family history of addiction with strong protective interest
Cost & financial impact
Pricing ranges with cited sources (SAMHSA TIP, MEPS, AHRQ, KFF).
Inpatient medical detox (ASAM Level 3.7 medically monitored withdrawal management) costs $5,000-$15,000 for a typical 5-7 day stay, covered by most insurance with prior auth. Hospital-based Level 4.0 detox (medically managed inpatient) costs $10,000-$25,000 for complex cases. Outpatient detox is significantly cheaper ($500-$2,000) but limited to substances safely managed outpatient (typically not alcohol or benzodiazepines). MAT costs vary by medication: generic buprenorphine-naloxone $10-$30/week with insurance ($80-$120 cash retail); methadone at OTPs $70-$120/week with insurance ($120-$200 cash); Vivitrol monthly injection $0-$200 with insurance + Alkermes copay assistance ($1,400 cash); generic oral naltrexone $20-$40/month; acamprosate $40-$80/month; disulfiram $10-$20/month. MAT is dramatically cheaper than ongoing relapse cycles.
Our verdict
Choose Medical Detox if...
acute withdrawal management (3-7 days) to safely stabilize the patient off substances before transitioning to longer-term recovery care
Learn more about Medical Detox →Choose MAT (Medication-Assisted Treatment) if...
long-term relapse prevention and recovery support (months to years) using FDA-approved medications buprenorphine, methadone, or naltrexone for OUD; naltrexone, acamprosate, or disulfiram for AUD
Learn more about MAT (Medication-Assisted Treatment) →Still not sure which is right for you?
The level of care is a clinical decision based on addiction severity, withdrawal risk, and your home situation — not just personal preference. A free, confidential 2-minute self-assessment can help you gauge severity before you call, and our team can verify your insurance and match you to the right level of care at no cost.
Frequently asked questions
Is detox enough to get sober?
For most substances, no. Detox manages acute physical withdrawal (3-7 days) but does not address the long-term drivers of substance use: cravings, behavioral patterns, environmental triggers, or co-occurring mental health. Detox alone for OUD has >80% relapse within 30 days per NIDA research. Detox should be the entry point to longer-term treatment (residential, IOP, or outpatient with MAT), not the entire intervention.
What is the difference between detox and MAT?
Detox is a short-term (3-7 day) intervention to safely manage acute withdrawal symptoms. MAT (Medication-Assisted Treatment) is long-term (months to years) use of FDA-approved medications (buprenorphine, methadone, naltrexone for OUD; naltrexone, acamprosate, disulfiram for AUD) to prevent relapse and support recovery. They serve different phases of treatment and are typically combined.
Can I start MAT during detox?
Yes — best practice is to initiate MAT during detox. For OUD: buprenorphine induction begins when withdrawal symptoms appear (typically 12-24 hours after last opioid use); the buprenorphine reduces withdrawal immediately and continues as long-term treatment. For AUD: naltrexone or acamprosate may be started during or just after alcohol detox. Vivitrol (extended-release naltrexone) requires 7-10 days opioid-free, so detox provides that window before first injection.
Is medical detox necessary for everyone?
No. Medical detox is necessary for alcohol and benzodiazepine withdrawal (seizure risk can be fatal) and helpful for severe opioid withdrawal. Stimulant (cocaine, methamphetamine) and cannabis withdrawal can typically be managed outpatient without medical detox. ASAM Criteria assessment determines the appropriate level.
Why is detox alone risky for opioid users?
Loss of tolerance during detox dramatically increases overdose risk if the patient relapses. A pre-detox tolerance dose becomes lethal after detox. NIDA research shows overdose mortality spikes in the 30 days post-detox when patients are not on MAT. SAMHSA TIP 63 explicitly states detox alone is not recommended for OUD; MAT must continue.
How long is MAT typically continued?
There is no fixed maximum duration. SAMHSA TIP 63 states MAT may be continued indefinitely for stable patients. Many patients remain on MAT for 1-5 years; some continue for life. The duration is determined clinically based on stability, relapse risk, and patient preference. Premature discontinuation increases relapse risk significantly.
Does insurance cover both detox and MAT?
Yes. Most insurance plans cover medical detox (ASAM Level 3.7 with prior auth, typically 3-7 days) and MAT (under SUD pharmacy + behavioral health benefits). MHPAEA federal parity prohibits insurers from imposing more restrictive limits on either than on comparable medical-surgical benefits. Generic buprenorphine is typically tier-1 ($10-$30/week); methadone at OTPs covered under weekly bundled rate; Vivitrol under medical benefit with prior auth.
Is MAT just replacing one drug with another?
No. Buprenorphine and methadone are pharmacologically opioids, but they are administered in controlled doses producing physical stability without intoxication, allowing patients to function normally. Naltrexone is a non-opioid that blocks opioid effects entirely. The medical view: untreated SUD is the disease; MAT is the treatment. The "replacement" framing is medically outdated per SAMHSA, NIDA, and WHO.
Can I detox at home?
For mild opioid withdrawal: with medical supervision and buprenorphine initiation, sometimes yes. For alcohol or benzodiazepine withdrawal: NO — seizure risk requires medical monitoring. For stimulants or cannabis: typically yes with adequate support. Always consult a physician before attempting home detox; severe withdrawal can be fatal.
How do I find detox + MAT programs?
Use SAMHSA Treatment Locator (findtreatment.gov or 1-800-662-4357) and filter for "Buprenorphine" or "Methadone Treatment" + "Medical Detoxification." Verify the facility initiates MAT during detox (best practice). Ask: do you start buprenorphine during the detox stay, or only refer out post-discharge? Facilities that integrate MAT with detox have significantly better outcomes.
Was this comparison helpful?
Need help deciding?
Free, confidential guidance from licensed advisors to help you choose between Medical Detox and MAT (Medication-Assisted Treatment).
Last reviewed: May 12, 2026 • Sourced from SAMHSA, NIDA, peer-reviewed literature • Reviewed by RehabHive Editorial Team • Editorial policy
